**Question:** All of the following statements regarding progressive multifocal leucoencephalopathy are true except aEUR'

A. Progressive multifocal leucoencephalopathy (PML) is a rare demyelinating disease caused by the JC virus.
B. PML primarily affects immunocompromised patients, such as those with HIV/AIDS.
C. PML is a rare disease affecting the central nervous system.
D. PML is a common cause of neurological symptoms in immunocompetent individuals.

**Correct Answer:** .

**Core Concept:**
Progressive multifocal leucoencephalopathy (PML) is a rare demyelinating disease caused by the JC virus. PML primarily affects immunocompromised patients, such as those with HIV/AIDS, due to the suppression of the immune system that prevents the clearance of the virus. PML is characterized by the destruction of the white matter in the brain and spinal cord, leading to neurological symptoms. PML is not commonly seen in immunocompetent individuals (those with a functioning immune system).

**Why the Correct Answer is Right:**
Option D is incorrect because PML is a rare disease affecting immunocompetent individuals. In contrast, PML primarily affects immunocompromised patients due to the inability to clear the JC virus from the body.

**Why Each Wrong Option is Incorrect:**
A is incorrect because PML is caused by the JC virus, which affects the central nervous system (CNS), but it is not the primary cause of demyelinating diseases. Demyelinating diseases have a broader range of causes, including multiple sclerosis and Guillain-Barré syndrome.

B is incorrect because PML predominantly affects immunocompromised patients, such as those with HIV/AIDS, rather than being a common cause of neurological symptoms in immunocompetent individuals.

**Why Each Wrong Option is Incorrect:**
C is incorrect because PML is a rare disease, not a common cause of neurological symptoms. Demyelinating diseases have a broader range of causes, including multiple sclerosis and Guillain-Barré syndrome.

**Clinical Pearl:**
Understanding the immunocompromised status and the involvement of the JC virus in PML is crucial for distinguishing PML from other neurological conditions. PML primarily affects immunocompromised patients, while demyelinating diseases encompass a broader range of causes. This distinction helps in appropriate diagnosis and treatment planning.